Aqua Bio Technology — AGM Information 2024

Nov 13, 2024

Aqua Bio Technology: Minutes from extraordinary general meeting - Completion of Private Placement and the Jetcarrier Transaction

Aqua Bio Technology: Minutes from extraordinary general meeting - Completion of Private Placement and the Jetcarrier Transaction

13.11.2024 13:59:25 CET | Aqua Bio Technology ASA | Additional regulated

information required to be disclosed under the laws of a member state

Aqua Bio Technology ASA ("ABT" or the "Company") has today held an extraordinary

general meeting. All resolutions were made in accordance with the proposals set

out in the notice for the extraordinary general meeting which means that the

Private Placement and Jetcarrier Transaction announced on

17 October have been completed. The minutes of the extraordinary general meeting

are attached to this notice.

Following the Jetcarrier Transaction, ABT owns all the shares in Jetcarrier AS

which owns 100 % of the shares in Jetcarrier Logistics AS, Isebakkeveien 75 AS,

Jetcarrier Solutions AS, Xpanz AS, Norlane AS, Jetcarrier AB, FreightWay AB and

Filial Magnoas, and represents a major logistic group in the Nordics.

For further information, please contact Jan Varming, CFO, telephone +47 90 83 90

About Aqua Bio Technology ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skincare products. ABT's cosmetics ingredients are

highly effective, and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skincare products developed by partners towards consumers and

professional users. ABT's focus on commercialization and development of natural

ingredients and natural skincare products has been, and will continue to be, an

important part of the Company's strategy going forward. ABT is listed on the

Euronext Expand market of the Oslo Stock Exchange.

This information is subject of the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/18322224/5241/Download%20announce

ment%20as%20PDF.pdf

Aqua Bio Technology ASA - Minutes of EGM 13 November 2024_37_.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/18322224/5240/Aqua%20Bio%20Techno

logy%20ASA%20-%20Minutes%20of%20EGM%2013%20November%202024_37_.pdf